1. Home
  2. AHH vs TRML Comparison

AHH vs TRML Comparison

Compare AHH & TRML Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

  • Machine Learning Prediction
  • ML Decision
  • AHH
  • TRML
  • Stock Information
  • Founded
  • AHH 1979
  • TRML 2021
  • Country
  • AHH United States
  • TRML United States
  • Employees
  • AHH N/A
  • TRML N/A
  • Industry
  • AHH Real Estate
  • TRML Biotechnology: Pharmaceutical Preparations
  • Sector
  • AHH Finance
  • TRML Health Care
  • Exchange
  • AHH Nasdaq
  • TRML Nasdaq
  • Market Cap
  • AHH 585.2M
  • TRML 598.9M
  • IPO Year
  • AHH 2013
  • TRML N/A
  • Fundamental
  • Price
  • AHH $7.47
  • TRML $47.71
  • Analyst Decision
  • AHH Buy
  • TRML Hold
  • Analyst Count
  • AHH 4
  • TRML 12
  • Target Price
  • AHH $8.38
  • TRML $47.04
  • AVG Volume (30 Days)
  • AHH 489.5K
  • TRML 1.7M
  • Earning Date
  • AHH 11-03-2025
  • TRML 11-06-2025
  • Dividend Yield
  • AHH 10.96%
  • TRML N/A
  • EPS Growth
  • AHH N/A
  • TRML N/A
  • EPS
  • AHH 0.13
  • TRML N/A
  • Revenue
  • AHH $544,168,000.00
  • TRML N/A
  • Revenue This Year
  • AHH N/A
  • TRML N/A
  • Revenue Next Year
  • AHH $4.50
  • TRML N/A
  • P/E Ratio
  • AHH $57.78
  • TRML N/A
  • Revenue Growth
  • AHH N/A
  • TRML N/A
  • 52 Week Low
  • AHH $6.10
  • TRML $11.56
  • 52 Week High
  • AHH $12.28
  • TRML $47.72
  • Technical
  • Relative Strength Index (RSI)
  • AHH 63.27
  • TRML 94.42
  • Support Level
  • AHH $7.36
  • TRML $22.31
  • Resistance Level
  • AHH $7.49
  • TRML $47.69
  • Average True Range (ATR)
  • AHH 0.15
  • TRML 1.09
  • MACD
  • AHH 0.02
  • TRML 2.26
  • Stochastic Oscillator
  • AHH 88.46
  • TRML 99.96

About AHH Armada Hoffler Properties Inc.

Armada Hoffler Properties Inc is a real estate company. It engages in developing, building, owning and managing the high-quality, institutional-grade office, retail, and multifamily properties in various markets throughout the Mid-Atlantic and Southeastern United States. It lease its properties under operating leases and recognize base rents. It also recognize revenue from tenant recoveries, through which tenants reimburses the company for expenses paid by them such as utilities, janitorial, repairs and maintenance. The company's operating segment includes office real estate, retail real estate, multifamily residential real estate, and general contracting, real estate financing and real estate services. It generates maximum revenue from the retail real estate segment.

About TRML Tourmaline Bio Inc.

Tourmaline Bio Inc is a late-stage clinical biotechnology company driven by its mission to develop transformative medicines that dramatically improve the lives of patients with life-altering immune diseases. Its initial product candidate is TOUR006, a fully human monoclonal antibody that selectively binds to interleukin-6 (IL-6), a key proinflammatory cytokine involved in the pathogenesis of many autoimmune and inflammatory disorders. The anti-IL-6 and anti-IL-6 receptor (IL-6R) antibody class (IL-6 class) has over two decades of clinical and commercial experience treating over a million patients with a variety of autoimmune and inflammatory diseases.

Share on Social Networks: